BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Institute of Biomedical Engineering (BME) - ECPv6.17.4.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Institute of Biomedical Engineering (BME)
X-ORIGINAL-URL:https://bme.utoronto.ca
X-WR-CALDESC:Events for Institute of Biomedical Engineering (BME)
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20240130T110000
DTEND;TZID=America/Toronto:20240130T120000
DTSTAMP:20240116T143934Z
CREATED:20240116T143934Z
LAST-MODIFIED:20240116T143934Z
UID:10000362-1706612400-1706616000@bme.utoronto.ca
SUMMARY:From publication to incorporation: How Arma Biosciences is designing a future of on-demand\, personalized health monitoring
DESCRIPTION:Please join us for an ECHO webinar featuring Dr. Surath Gomis\, who will provide an overview of Arma Biosciences\, its technologies and the story behind its success. \n  \nArma Biosciences is a seed stage company developing a real-time\, first in class\, and mobile clinical-grade biomarker monitoring device to revolutionize at-home patient care. https://www.arma-bio.com/ \n  \nWebinar Title \n  \nFrom publication to incorporation: How Arma Biosciences is designing a future of on-demand\, personalized health monitoring \n  \nGuest Speaker \n  \nSurath Gomis\, PhD \nCo-Founder and Director of R&D\, Arma Biosciences \n \n\n\nDate & Time \n  \nTuesday January 30\, 2024 (11 am – 12 pm EST) \n \n\n\nRegister in advance for this webinar. After registering\, you will receive a confirmation email containing information about joining the webinar. \n \n\n\n  \n  \nECHO is an entrepreneurship training program\, funded and organized in a partnership between (i) the Translational Biology and Engineering Program (TBEP)\, the University of Toronto component of the Ted Rogers Centre for Heart Research\, and (ii) the Health Innovation Hub (H2i). For more information\, visit: https://tedrogersresearch.ca/echo/
URL:https://bme.utoronto.ca/event/from-publication-to-incorporation-how-arma-biosciences-is-designing-a-future-of-on-demand-personalized-health-monitoring/
CATEGORIES:Events & Workshops
ORGANIZER;CN="Translational Biology and Engineering Program (TBEP)":MAILTO:reception.tbep@utoronto.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20231115T110000
DTEND;TZID=America/Toronto:20231115T120000
DTSTAMP:20231101T193907Z
CREATED:20231101T193907Z
LAST-MODIFIED:20231101T193907Z
UID:10000300-1700046000-1700049600@bme.utoronto.ca
SUMMARY:TBEP Research Seminar (Dr. Sheng Xu): Wearable ultrasound technology for monitoring deep tissues
DESCRIPTION:Dr. Sheng Xu (University of California San Diego\, Associate Professor and Jacobs Faculty Scholar) will demonstrate a soft ultrasonic technology that can noninvasively and continuously acquire dynamic information about deep tissues and central organs. He will also showcase examples of this technology’s use in recording blood pressure and flow waveforms in central vessels\, monitoring cardiac chamber activities\, and measuring core body temperatures. The soft ultrasonic technology presented represents a platform with vast potential for applications in consumer electronics\, defense medicine\, and clinical practices.
URL:https://bme.utoronto.ca/event/tbep-research-seminar-dr-sheng-xu-wearable-ultrasound-technology-for-monitoring-deep-tissues/
CATEGORIES:External Speaker Series
ORGANIZER;CN="Translational Biology and Engineering Program (TBEP)":MAILTO:reception.tbep@utoronto.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230620T110000
DTEND;TZID=America/Toronto:20230620T120000
DTSTAMP:20230607T141938Z
CREATED:20230607T141938Z
LAST-MODIFIED:20230607T141938Z
UID:10000224-1687258800-1687262400@bme.utoronto.ca
SUMMARY:The Journey from Concept to Commercial
DESCRIPTION:  \nPlease join us for an ECHO webinar featuring Garrett Schwab\, who will provide an overview of his vast experience developing and commercializing novel therapeutic medical technologies. \nXII Medical is a privately held medical technology company developing a novel neurostimulation system designed to improve patient experience and outcomes for the millions suffering from Obstructive Sleep Apnea. \nGuest Speaker\nGarrett Schwab\, BA\, MBA \nPresident and CEO\, XII Medical \nRegister in advance for this webinar. After registering\, you will receive a confirmation email containing information about joining the webinar.\nECHO is an entrepreneurship training program\, funded and organized in a partnership between (i) the Translational Biology and Engineering Program (TBEP)\, the University of Toronto component of the Ted Rogers Centre for Heart Research\, and (ii) the Health Innovation Hub (H2i). For more information\, visit: https://tedrogersresearch.ca/echo/
URL:https://bme.utoronto.ca/event/the-journey-from-concept-to-commercial/
CATEGORIES:Events & Workshops
ORGANIZER;CN="Translational Biology and Engineering Program (TBEP)":MAILTO:reception.tbep@utoronto.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230530T110000
DTEND;TZID=America/Toronto:20230530T120000
DTSTAMP:20230504T155027Z
CREATED:20230504T155027Z
LAST-MODIFIED:20230504T155027Z
UID:10000219-1685444400-1685448000@bme.utoronto.ca
SUMMARY:Start-up Lessons: Concept to Commercialization of a Wearable Medical Monitoring Solution for Acute Care Patients
DESCRIPTION:  \nPlease join us for an ECHO webinar featuring Dr. Devin McCombie\, who will provide an overview of his vast experience commercializing wearable medical monitoring solutions at Sotera and Dexcom. \nDexcom Inc. develops\, manufactures\, produces\, and distributes continuous glucose monitoring systems for diabetes management. Sotera Inc. is a digital health start-up company that commercialized and sold a first-of-its-kind wearable vital sign monitoring solution to detect deterioration of acute care patients on the hospital general ward. \n  \nGuest Speaker \nDr. Devin McCombie\, PhD \nPast CEO\, Sotera Digital Health \nPresident\, Theorem Medtech LLC \nPrincipal Tech Lead\, Dexcom Inc. \n  \nRegister in advance for this webinar. After registering\, you will receive a confirmation email containing information about joining the webinar. \nECHO is an entrepreneurship training program\, funded and organized in a partnership between (i) the Translational Biology and Engineering Program (TBEP)\, the University of Toronto component of the Ted Rogers Centre for Heart Research\, and (ii) the Health Innovation Hub (H2i). For more information\, visit: https://tedrogersresearch.ca/echo/
URL:https://bme.utoronto.ca/event/start-up-lessons-concept-to-commercialization-of-a-wearable-medical-monitoring-solution-for-acute-care-patients/
CATEGORIES:Events & Workshops
ORGANIZER;CN="Translational Biology and Engineering Program (TBEP)":MAILTO:reception.tbep@utoronto.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230228T110000
DTEND;TZID=America/Toronto:20230228T120000
DTSTAMP:20230207T175407Z
CREATED:20230207T175407Z
LAST-MODIFIED:20230207T175407Z
UID:10000190-1677582000-1677585600@bme.utoronto.ca
SUMMARY:Translating 3D Bioprinting Tools From Lab to Market: an Academic’s Perspective on Starting a Company
DESCRIPTION:Please join us for an ECHO webinar featuring Prof. Stephanie Willerth\, who will provide an overview of Axolotl Biosciences\, its technologies and the story behind its success. \nAxolotl Biosciences – an award-winning spin-off company from the University of Victoria – sells high quality reagents for 3D printing human tissue models. https://www.axolotlbiosciences.com/  \n\nGuest Speaker\nProf. Stephanie Willerth\, PhD\, PEng \nChief Executive Officer\, Axolotl Biosciences \nProfessor and Canada Research Chair in Biomedical Engineering\, University of Victoria \n\nRegister in advance for this webinar. After registering\, you will receive a confirmation email containing information about joining the webinar. \nECHO is an entrepreneurship training program\, funded and organized in a partnership between (i) the Translational Biology and Engineering Program (TBEP)\, the University of Toronto component of the Ted Rogers Centre for Heart Research\, and (ii) the Health Innovation Hub (H2i). For more information\, visit: https://tedrogersresearch.ca/echo/
URL:https://bme.utoronto.ca/event/translating-3d-bioprinting-tools-from-lab-to-market-an-academics-perspective-on-starting-a-company/
CATEGORIES:External Speaker Series
ORGANIZER;CN="Translational Biology and Engineering Program (TBEP)":MAILTO:reception.tbep@utoronto.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20221207T110000
DTEND;TZID=America/Toronto:20221207T120000
DTSTAMP:20221121T210335Z
CREATED:20221121T210335Z
LAST-MODIFIED:20221121T210335Z
UID:10000159-1670410800-1670414400@bme.utoronto.ca
SUMMARY:TBEP Research Seminar: Defining the cardiac fibroblast and its role in health and disease
DESCRIPTION:Jeffery Molkentin\, Ph.D.\nDivision Director of Molecular Cardiovascular Biology and Heart Institute Co-Director\, Cincinnati Children’s Hospital \nProfessor of Pediatrics\, University of Cincinnati Children’s Hospital Medical Center \nRegister for the seminar via Zoom \nAbstract: Collagen production in the adult heart is primarily mediated by the tissue resident interstitial fibroblast. Indeed\, adult fibroblast-specific deletion of the molecular chaperones required for procollagen biosynthesis\, heat-shock protein 47 (Hsp47)\, prevents new fibrillar collagen production in the adult heart. More specifically\, myofibroblast-specific ablation of Hsp47 blocked fibrosis and deposition of collagens type-I\, -III and -V following pressure overload\, which unexpectedly significantly reduced cardiac hypertrophy. These results suggested that an inability to generate new supportive ECM material by cardiac fibroblasts in response to pressure overload was sensed by the cardiomyocyte as it attempted to hypertrophy. To examine this potential mechanism further we also generated Col1a2-loxP targeted mice so that fibroblast specific deletion could be performed to then examine the hypothesis that reduced structural rigor of the newly synthesized type I fibrillar collagen network in the pressure loaded mouse heart would not support the same degree of cardiac hypertrophy. Indeed\, myofibroblast- specific deletion of Col1a2 in the adult heart following 1 week of pressure overload compromised the hypertrophic response. Importantly\, deletion of Col1a2 from the heart resulted in reduced stiffness and structural integrity\, at both baseline with developmental deletion as well as in the adult heart with inducible deletion. Unexpectedly\, developmental deletion of Col1a2 from the mouse heart resulted in a secondary fibrotic response with increased fibroblast number\, which is likely a compensatory response to the decreased stiffness of the ECM due to defective type I collagen. Collectively our results suggest that the cardiac fibroblast communicates with the cardiomyocyte in the heart through the integrity of the ECM\, which also effects fibroblast dynamics.
URL:https://bme.utoronto.ca/event/tbep-research-seminar-defining-the-cardiac-fibroblast-and-its-role-in-health-and-disease/
CATEGORIES:External Speaker Series
ORGANIZER;CN="Translational Biology and Engineering Program (TBEP)":MAILTO:reception.tbep@utoronto.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20221020T110000
DTEND;TZID=America/Toronto:20221020T120000
DTSTAMP:20220929T144006Z
CREATED:20220927T195752Z
LAST-MODIFIED:20220929T144006Z
UID:10000129-1666263600-1666267200@bme.utoronto.ca
SUMMARY:TBEP Research Seminar: The role of synthetic pulse wave data in the development of technologies to assess cardiovascular function
DESCRIPTION:Jordi Alastruey\, Ph.D. \nSenior Lecturer \nSchool of Biomedical Engineering and Imaging Sciences\, King’s College London \n***This is a Zoom only event\nJordi Alastruey received the M.Sc. degree in civil engineering from the Universitat Politècnica de Catalunya\, Barcelona\, Spain\, in 2002\, and the Ph.D. degree in biomedical engineering from Imperial College London (ICL)\, London\, U.K.\, in 2006. In 2009 he was awarded a British Heart Foundation Research Fellowship; began his fellowship at ICL before moving to King’s College London in 2011\, where he is currently a Senior Lecturer with the School of Biomedical \nEngineering and Imaging Sciences. He leads the Haemodynamic Modelling Research Group which specialises in the assessment of cardiovascular function based on the analysis of pulse wave (PW) signals. These signals are influenced by the heart\, vasculature\, and respiratory and autonomic nervous systems\, making them a rich source of information to assess human health. \nHe and his colleagues develop novel models for simulating PW signals\, such as blood pressure and photoplethysmogram waves\, under a variety of physiological and pathophysiological \nconditions. They develop methods for calibrating these models and understanding the physical mechanisms underlying their results. They also investigate signal processing techniques to assess the functions of the cardiovascular\, respiratory\, and autonomic nervous systems from PW signals acquired by a variety of devices\, including wearable sensors. The seminar will focus on the simulation of PW signals using biophysical modelling and on the creation of \ndatasets of synthetic PWs representative of samples of real subjects. These datasets are a cost-effective approach for the development and pre-clinical testing of technologies to assess cardiovascular function under a wide range of physiological conditions. They also allow us to understand biophysical mechanisms underlying correlations observed from populations of real subjects and train machine-learning algorithms for PW analysis. The seminar will present the benefits of using synthetic PW datasets in the assessment of vascular ageing and arterial hypertension from PW signals.
URL:https://bme.utoronto.ca/event/tbep-research-seminar-the-role-of-synthetic-pulse-wave-data-in-the-development-of-technologies-to-assess-cardiovascular-function/
CATEGORIES:External Speaker Series
ORGANIZER;CN="Translational Biology and Engineering Program (TBEP)":MAILTO:reception.tbep@utoronto.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20221013T150000
DTEND;TZID=America/Toronto:20221013T200000
DTSTAMP:20221005T181549Z
CREATED:20220914T192453Z
LAST-MODIFIED:20221005T181549Z
UID:10000116-1665673200-1665691200@bme.utoronto.ca
SUMMARY:ECHO Pitch 2022
DESCRIPTION:Igniting Cardiovascular Innovation\nJoin us at ECHO PITCH 2022: a special event where five start-ups in the cardiovascular health sector will compete live for up to $250\,000 \nbefore a panel of judges. All are welcome to register and be part of the live audience! \nWHEN: Thursday Oct. 13\, 2022\, 3:00-8:00 PM \nWHERE: Malaparte – TIFF Bell Lightbox (350 King St. W.\, 6th Floor\, Toronto) \nWHAT: \n\nWatch five inspiring innovators of cardiovascular technologies pitch their novel ideas.\nMeet\, connect and share ideas with exceptional entrepreneurs\, scientists\, clinicians\, business leaders and investors.\nGain insights from a multi-sectoral panel of judges as well as expert keynote speakers.\nEnjoy an afternoon of entertainment\, food and beverages.\n\nFor all the details please visit our event page – space is limited so reserve your spot soon! \nThe Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program is funded and organized by the Translational Biology and \nEngineering Program\, at the University of Toronto and the Ted Rogers Centre for Heart Research\, in partnership with the Health \nInnovation Hub (H2i). For more information on the ECHO program\, please visit: https://tedrogersresearch.ca/echo
URL:https://bme.utoronto.ca/event/38795/
CATEGORIES:Events & Workshops
ATTACH;FMTTYPE=image/png:https://bme.utoronto.ca/wp-content/uploads/2022/09/thumbnail_image001.png
ORGANIZER;CN="Translational Biology and Engineering Program (TBEP)":MAILTO:reception.tbep@utoronto.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220927T110000
DTEND;TZID=America/Toronto:20220927T120000
DTSTAMP:20220907T140311Z
CREATED:20220907T140311Z
LAST-MODIFIED:20220907T140311Z
UID:10000096-1664276400-1664280000@bme.utoronto.ca
SUMMARY:TBEP Research Seminar: Wnt in heart formation and regeneration
DESCRIPTION:Daniela Panáková\, Ph.D. \nGroup Leader \nMax Delbrück Center\, Berlin\, Germany \nDaniela Panáková received her PhD in 2005 at Max Planck Institute of Molecular Cell Biology and Genetics\, Dresden\, Germany under the supervision of Suzanne Eaton. She has worked with Drosophila model on the concept of how the hydrophobic morphogens such as Wnt can spread in tissues over long distances\, and identified a novel mechanism whereby lipoprotein particles act as vehicles for the lipid-linked proteins\, and are required for Wingless and Hedgehog signaling. In 2007\, as a Human Frontier Science Program Long-term Fellow she moved to Harvard Medical School/Brigham & Women’s Hospital\, Boston\, MA to work with Calum MacRae. Using zebrafish\, she has demonstrated non-canonical Wnt signaling modulates electrical coupling in the developing heart through negative regulation of L-type Ca2+ channel function\, which established a novel limb in non-canonical Wnt signaling. She was awarded highly esteemed Helmholtz Young Investigator Award to start her own research lab at Max Delbrück Center in Berlin\, Germany in 2011. Teaching\, training and mentoring form a great part of her endeavors as an independent investigator. She has served as a Confidential Advisor for both the PhD and Postdoc body at the MDC and was part of the Gender Equality and Equal Opportunity team at the MDC. \nDaniela Panáková’s long-standing research interest addresses how developmental signaling and physiology regulate cellular responses including cell fate and differentiation. Her main focus is to decipher how Wnt pathway interacts with mechanical and electrical cues in cell and zebrafish models. Her group made significant contributions to the understanding of heart formation and function\, and more recently also to heart regeneration. Her ultimate goal is to uncover cellular mechanisms underlying cardiovascular diseases including heart failure. Her research focuses on cardiac biology\, but on the broader scale has implication for cell\, tissue and organ biology.
URL:https://bme.utoronto.ca/event/tbep-research-seminar-wnt-in-heart-formation-and-regeneration/
CATEGORIES:External Speaker Series
ORGANIZER;CN="Translational Biology and Engineering Program (TBEP)":MAILTO:reception.tbep@utoronto.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220808
DTEND;VALUE=DATE:20220809
DTSTAMP:20220623T133551Z
CREATED:20220623T133551Z
LAST-MODIFIED:20220623T133551Z
UID:10000045-1659916800-1660003199@bme.utoronto.ca
SUMMARY:Entrepreneurship for Cardiovascular Health Opportunities (ECHO): CALL FOR APPLICATIONS
DESCRIPTION:Entrepreneurship for Cardiovascular Health Opportunities (ECHO): CALL FOR APPLICATIONS \n  \nTo reach teams across Canada\, ECHO is a fully virtual program. \n  \nWe are pleased to announce a call for applications for the 2022-2023 ECHO program! \n\nFounded in 2018\, ECHO is a 12-month online training program led by veteran entrepreneurs and high-calibre consultants across a variety of sectors. Comprised of a unique combination of five complementary modules\, ECHO provides innovators of cardiovascular technologies with entrepreneurship training\, mentorship\, and networking opportunities\, and the chance to pitch for start-up funding from a $250\,000 pool. \n\nPlease see the attached brochure. You can also visit our webpage at https://tedrogersresearch.ca/ECHO/ for program details\, instructions and application forms. Applications are due Monday\, August 8\, 2022. \n\nIf you have any questions regarding ECHO\, please contact Soror Sharifpoor (soror.sharifpoor@utoronto.ca). \n\nECHO is organized and funded by the Translational Biology and Engineering Program (TBEP) – the University of Toronto component of the Ted Rogers Centre for Heart Research – in partnership with the Health Innovation Hub (H2i)\, a University of Toronto campus-linked accelerator.
URL:https://bme.utoronto.ca/event/entrepreneurship-for-cardiovascular-health-opportunities-echo-call-for-applications/
CATEGORIES:Events & Workshops
ORGANIZER;CN="Translational Biology and Engineering Program (TBEP)":MAILTO:reception.tbep@utoronto.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220621T110000
DTEND;TZID=America/Toronto:20220621T120000
DTSTAMP:20220603T151630Z
CREATED:20220603T151630Z
LAST-MODIFIED:20220603T151630Z
UID:10000028-1655809200-1655812800@bme.utoronto.ca
SUMMARY:Insights from the Endotronix Journey: A PMA Medtech “Startup" Story
DESCRIPTION:Please join us for an ECHO webinar on Tuesday June 21\, 2022 (11 am – 12 pm EST) featuring Dr. Harry Rowland (CEO and Co-founder\, Endotronix). Dr. Rowland’s presentation entitled\, “Insights from the Endotronix Journey: A PMA Medtech “Startup” Story”\, will feature an overview of Endotronix\, its technologies and the story behind its success. Endotronix is a medical technology company\, delivering an integrated platform that provides comprehensive\, reimbursable health management innovations for patients suffering from advanced heart failure. Please see attachment for more details. \n\nRegister in advance for this webinar: https://us02web.zoom.us/meeting/register/tZwkc-GrqD0sGtcnluN7KLI2wNtAxZ1kYIx9 \nAfter registering\, you will receive a confirmation email containing information about joining the webinar. \n  \nECHO is an entrepreneurship training program\, funded and organized in a partnership between (i) the Translational Biology and Engineering Program (TBEP)\, the University of Toronto component of the Ted Rogers Centre for Heart Research\, and (ii) the Health Innovation Hub (H2i).
URL:https://bme.utoronto.ca/event/insights-from-the-endotronix-journey-a-pma-medtech-startup-story/
CATEGORIES:External Speaker Series
ORGANIZER;CN="Translational Biology and Engineering Program (TBEP)":MAILTO:reception.tbep@utoronto.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220531T110000
DTEND;TZID=America/Toronto:20220531T120000
DTSTAMP:20220510T195824Z
CREATED:20220510T192503Z
LAST-MODIFIED:20220510T195824Z
UID:10000008-1653994800-1653998400@bme.utoronto.ca
SUMMARY:Reimagining the Jugular Venous Pressure: The Evolution of a Medical Technology Start-up
DESCRIPTION:Please join us for an ECHO webinar on Tuesday May 31\, 2022 (11 am – 12 pm EST) featuring Dr. Andrew J Smith (CSO and Co-Founder\, JVPLabs). Dr. Smith’s presentation entitled\, “Reimagining the Jugular Venous Pressure: The Evolution of a Medical Technology Start-up”\, will feature an overview of JVPLabs\, its technologies and the story behind its success. JVPLabs is a medical device company founded in 2016 by two physicians\, Dr. Andrew Smith (Emergency Medicine) and Dr. Jason Roberts (Cardiology). The focus of the company is to develop a leading edge non-invasive technology to improve and enable assessment of Congestive Heart Failure (CHF) patients via the JVP height\, in hospital and remotely\, at home. Please see attachment for more details.
URL:https://bme.utoronto.ca/event/reimagining-the-jugular-venous-pressure-the-evolution-of-a-medical-technology-start-up/
CATEGORIES:External Speaker Series
ATTACH;FMTTYPE=image/jpeg:https://bme.utoronto.ca/wp-content/uploads/2022/05/thumbnail_ECHO-Webinar-Andrew-J-Smith-JVPLabs-May-31-2022-Social-media-e1652210852247.jpg
ORGANIZER;CN="Translational Biology and Engineering Program (TBEP)":MAILTO:reception.tbep@utoronto.ca
END:VEVENT
END:VCALENDAR